Clinical Infectious Disease Tests
Respiratory Infections (COVID-19, Flu, RSV, etc.)
CommercialActive
Key Facts
Indication
Respiratory Infections (COVID-19, Flu, RSV, etc.)
Phase
Commercial
Status
Active
Company
About ProGnosis Biotech
ProGnosis Biotech is an EU-based diagnostics company founded in 2015, developing and manufacturing ELISA and Lateral Flow Tests for food safety, clinical diagnostics, and hygiene monitoring. The company leverages its antigen-antibody technology platform to deliver rapid, reliable, and eco-friendly testing solutions validated by international bodies. With ISO-certified production and a growing portfolio, ProGnosis serves global markets while expanding into new areas like cardiac markers and contract manufacturing services.
View full company profile